Trials / Completed
CompletedNCT06408948
A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers
Phase I Clinical Trial of Mass Balance of [14C]SHR7280 in Healthy Chinese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the Mass Balance of \[14C\]SHR7280 in Healthy Adult Volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]SHR7280 | Patients will receive single dose of orally \[14C\]SHR7280 on Day 1. |
Timeline
- Start date
- 2024-06-07
- Primary completion
- 2024-07-06
- Completion
- 2024-07-06
- First posted
- 2024-05-10
- Last updated
- 2024-07-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06408948. Inclusion in this directory is not an endorsement.